Kishino Yuki, Hasegawa Tomoko, Kato Ayako, Nishiya Yumi, Rozhnal Veronika, Watanabe Kyoko, Takasaki Wataru, Yamoto Takashi, Mori Kazuhiko
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo, 134-8630, Japan.
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo, 134-8630, Japan.
Mutat Res Genet Toxicol Environ Mutagen. 2019 Feb;838:37-45. doi: 10.1016/j.mrgentox.2018.11.016. Epub 2018 Dec 5.
We investigated the relationship between metabolic activities of cytochrome P450 (CYP) isozymes present in microsomal fractions derived from the livers of 78 donors and micronucleus induction by cyclophosphamide (CPA). Consequently, a wide inter-individual variation in CYP activities was observed among the 78 donors. The CYP activities were partially correlated with the metabolic phenotypes predicted for the donors based on their single nucleotide polymorphisms. In addition, CPA induced micronucleus formation was seen for 47 out of 52 donors whose samples were tested with CPA doses ranging from 18.8 to 100 μg/mL. The CPA dose at which micronucleated cells were observed varied among the donors. Furthermore, a close correlation was identified between the catalytic activities of the CYP2B6, CYP2C9, CYP2C19, and CYP3A4 isozymes and micronucleus induction by CPA. To elucidate the mechanism underlying CPA-induced micronucleus formation in vitro tests were conducted on expression systems of CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. Additionally, the metabolites of CPA generated by the expression systems were quantified by a liquid chromatography tandem mass spectrometer. Interestingly, several metabolites including the 4-hydroxyl form of CPA (4-OH-CPA) and phosphamide mustard were detected in the CYP2B6, CYP2C19, and CYP3A4 expression systems, but not in the CYP2C9 and CYP2D6 system. The presence of these metabolites was correlated with micronucleus induction by CPA. The absence of CPA metabolites in the CYP2C9 expression system might be associated with the lower 4-hydroxylase activity of this system. The present results suggest that inter-individual variability in the metabolic capacity of each donor was associated with potential micronucleus induction due to CPA. Additionally, CPA metabolites like 4-OH-CPA and phosphamide mustard produced by human CYP2B6, CYP2C9, CYP2C19, and CYP3A4 are suggested to be major determinants of micronucleus induction by CPA.
我们研究了来自78名供体肝脏的微粒体组分中细胞色素P450(CYP)同工酶的代谢活性与环磷酰胺(CPA)诱导微核之间的关系。结果发现,78名供体之间CYP活性存在广泛的个体差异。CYP活性与基于单核苷酸多态性预测的供体代谢表型部分相关。此外,在52名用18.8至100μg/mL的CPA剂量进行测试的供体中,有47名观察到CPA诱导的微核形成。观察到微核细胞的CPA剂量在供体之间有所不同。此外,还发现CYP2B6、CYP2C9、CYP2C19和CYP3A4同工酶的催化活性与CPA诱导的微核之间存在密切相关性。为了阐明CPA诱导微核形成的机制,对CYP2B6、CYP2C9、CYP2C19、CYP2D6和CYP3A4的表达系统进行了体外试验。此外,通过液相色谱串联质谱仪对表达系统产生的CPA代谢产物进行了定量。有趣的是,在CYP2B6、CYP2C19和CYP3A4表达系统中检测到了几种代谢产物,包括CPA的4-羟基形式(4-OH-CPA)和磷酰胺氮芥,但在CYP2C9和CYP2D6系统中未检测到。这些代谢产物的存在与CPA诱导的微核相关。CYP2C9表达系统中不存在CPA代谢产物可能与该系统较低的4-羟化酶活性有关。目前的结果表明,每个供体代谢能力的个体差异与CPA诱导的潜在微核有关。此外,人CYP2B6、CYP2C9、CYP2C19和CYP3A4产生的4-OH-CPA和磷酰胺氮芥等CPA代谢产物被认为是CPA诱导微核的主要决定因素。